← Leaderboards
David E Hoke
University Of Melbourne
$163,804
Attributed
$163,804
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$163,804 · 1
By mechanism
F32$163,804 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Melbourne
Same institution · by research overlap
- Colin Masters$10,863,646
Others in their field
Top investigators on “Alzheimer'S Disease”
- Paul S. Aisen · Cognition Therapeutics, Inc.$200,724,578
- Randall J Bateman · Washington University$184,115,182
- Michael W Weiner · Northern California Institute Res &Educ$175,732,070
- Reisa A. Sperling · Banner Health$139,117,861
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$124,251,847
- Sid E O'Bryant · University Of North Texas Hlth Sci Ctr$124,049,392
Research focus
Alzheimer'S DiseaseAmyloid ProteinsCell Free SystemEndopeptidasesEnzyme ActivityPresenilin
Grant awards (8)
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$42,648
F32 · FY2004 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$5,500
F32 · FY2004 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$40,920
F32 · FY2003 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$5,500
F32 · FY2003 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$32,820
F32 · FY2002 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$5,500
F32 · FY2002 · AG
CHARACTERIZATION GAMMA-SEC ACTIVITY CELL FREE SYSTEM$26,916
F32 · FY2000 · AG
CHARACTERIZATION GAMMA SEC ACTIVITY CELL FREE SYSTEM$4,000
F32 · FY2000 · AG